EUR 44.74
(4.78%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 3.87 Billion | 3.9 Billion | 3.85 Billion | 3.34 Billion | 3.44 Billion | 3.27 Billion |
Cost of Revenue | 2.11 Billion | 1.39 Billion | 1.32 Billion | 1.15 Billion | 1.13 Billion | 1.09 Billion |
Gross Profit | 1.76 Billion | 2.51 Billion | 2.53 Billion | 2.18 Billion | 2.3 Billion | 2.18 Billion |
Operating Expenses | 897 Million | 1 Billion | 843 Million | 760 Million | 861 Million | 958 Million |
Selling, General and Administrative Expenses | 870 Million | 871 Million | 811 Million | 742 Million | 828 Million | 0.12 |
Research and Development Expenses | 27 Million | 31 Million | 40 Million | 44 Million | 43 Million | 0.16 |
Other Expenses | - | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
Cost and Expenses | 3.01 Billion | 2.81 Billion | 2.6 Billion | 2.4 Billion | 2.48 Billion | 2.18 Billion |
Operating Income | 865 Million | 1.08 Billion | 1.25 Billion | 940 Million | 953 Million | 609 Million |
Interest Expense | 267 Million | 248 Million | 244 Million | 224 Million | 231 Million | 230 Million |
Income Tax Expense | 224 Million | 271 Million | 304 Million | 204 Million | 220 Million | 825 Million |
Earnings before Tax | 778 Million | 800 Million | 1 Billion | 699 Million | 690 Million | 39 Million |
Net Income | 552 Million | 594 Million | 780 Million | 556 Million | 511 Million | 786 Million |
Earnings Per Share Basic | 2.76 | 2.97 | 3.90 | 2.78 | 2.56 | 2.01 |
Earnings Per Share Diluted | 2.76 | 2.97 | 3.90 | 2.78 | 2.56 | 402.04 Million |
Weighted Average Shares Outstanding | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 391 Million |
Weighted Average Shares Outstanding (Diluted) | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 1.96 |
Gross Margin | 0.45 | 0.64 | 0.66 | 0.65 | 0.67 | 0.67 |
EBIT Margin | 0.23 | 0.31 | 0.35 | 0.30 | 0.30 | 0.83 |
Profit Margin | 0.14 | 0.15 | 0.20 | 0.17 | 0.15 | 0.24 |
EBITDA | 897 Million | 1.2 Billion | 1.33 Billion | 1 Billion | 1.02 Billion | 618 Million |
Earnings Before Tax Margin | 0.22 | 0.28 | 0.32 | 0.28 | 0.28 | 0.19 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 2.02 Billion | 609 Million | 3.83 Billion | 1.93 Billion | 622 Million | 1.89 Billion |
Cost of Revenue | 1.11 Billion | 227 Million | 1.29 Billion | 648 Million | 220 Million | 646 Million |
Gross Profit | 906 Million | 382 Million | 2.54 Billion | 1.28 Billion | 402 Million | 1.25 Billion |
Operating Expenses | 405 Million | 217 Million | 1.53 Billion | 516 Million | 234 Million | 454 Million |
Selling, General and Administrative Expenses | 405 Million | - | - | 457 Million | - | 413 Million |
Research and Development Expenses | - | - | - | 27 Million | - | - |
Other Expenses | -757 Million | 44 Million | -1.53 Billion | 0.19 | 44 Million | 0.20 |
Cost and Expenses | 1.52 Billion | 444 Million | 2.83 Billion | 1.43 Billion | 454 Million | 1.32 Billion |
Operating Income | 501 Million | 165 Million | 1 Billion | 499 Million | 168 Million | 578 Million |
Interest Expense | - | - | 267 Million | 133 Million | - | 210 Million |
Income Tax Expense | 137 Million | 63 Million | 224 Million | 109 Million | 64 Million | 115 Million |
Earnings before Tax | 447 Million | 209 Million | 735 Million | 364 Million | 211 Million | 371 Million |
Net Income | 308 Million | 146 Million | 552 Million | 269 Million | 147 Million | 282 Million |
Earnings Per Share Basic | 1.54 | - | - | 1.35 | - | 1.41 |
Earnings Per Share Diluted | 1.54 | - | - | 1.35 | - | 1.41 |
Weighted Average Shares Outstanding | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
Weighted Average Shares Outstanding (Diluted) | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
Gross Margin | 0.45 | 0.63 | 0.66 | 0.67 | 0.65 | 0.66 |
EBIT Margin | 0.25 | - | - | 0.27 | - | 0.32 |
Profit Margin | 0.15 | 0.24 | 0.14 | 0.14 | 0.24 | 0.15 |
EBITDA | 512 Million | - | - | 518 Million | - | 601 Million |
Earnings Before Tax Margin | 0.25 | 0.27 | 0.26 | 0.26 | 0.27 | 0.30 |
KOHINOOR
KLINIQ
300031
002117
TIIL
PCSA